Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Hormone Deficiencies Clinical Trials

A listing of Hormone Deficiencies medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (31) clinical trials

Subjects with MLIV are seen annually for 5 years to assess ongoing for physical and neurological changes associated with the disease.

Phase N/A

Growth and Asymmetric diMethylArginine

Principal objective : Validation of a handy biochemical parameter, plasma concentration of Asymmetric DimethylArginine (ADMA), based on a recognize biochemical parameter, the dilation of the brachial artery, at ultrasound examination, after the deflation of a cushion to evaluate artery dysfunction (vascular suffering) in growth diseases, growth hormone deficiency (GHD) and ...

Phase N/A

Wolfram Syndrome International Registry and Clinical Study

Background Wolfram syndrome (OMIM #222300) is an autosomal recessive disorder characterized by insulin dependent diabetes mellitus (DM) in the first decade of life, followed by optic atrophy (OA), blindness, and deafness. Death from widespread neurodegeneration occurs in the third or fourth decades. Postmortem studies revealed a non-autoimmune loss of pancreatic ...

Phase N/A

Study on Application of Suturing Parathyroid Markers in Thyroid Cancer Surgery

This is a prospective randomized controlled study.In the experimental group, the suture parathyroid marker method was used to mark the parathyroid gland at the first time when it shows, and this marker was further used to identify and locating the inferior parathyroid marker in subsequent central region dissection. In the ...

Phase N/A

Seoul National University Pituitary Disease Cohort Study

Subjects for this study will be recruited if they are: Adults, male or female aged 18 years or older Have been diagnosed with pituitary diseases

Phase N/A

Effects of Hormonal Anabolic Deficiency and Neurovascular Alterations on Mortality in Male Patients With Heart Failure

One hundred and fifty six patients have been enrolled so far. Methods were as described below Muscle sympathetic nerve activity (MSNA) was directly recorded from the peroneal nerve using the microneurography technique ; All patients underwent symptom-limited cardiopulmonary exercise test performed on a cycle ergometer, using a ramp protocol with ...

Phase N/A

Dynamic Hormone Diagnostics in Endocrine Disease

Microdialysis fluid will be collected from all participants using the ULTRADIAN dynamic diagnostics system. This is a 3-component collection system which can easily be attached to a belt and allows participants to continue with their normal everyday activities whilst undergoing sampling. The micro-fractions are minute, the volume would normally be ...

Phase N/A

Long-term Safety and Effectiveness of Growth Hormone With GHD TS CRF SGA and ISS in Children

The purpose of this study is to evaluate the long-term safety and effectiveness of growth hormone (Eutropin Inj./Eutropin plus Inj.) treatment with GHD (Growth Hormone Deficiency), TS (Turner Syndrome),CRF (Chronic Renal Failure), SGA (Small for Gestational Age), and ISS (Idiopathic Short Stature).

Phase N/A

Lipolytic Effects of GH in Hypopituitary Patients in Vivo

Growth hormone (GH) is essential for longitudinal bone growth and somatic development. These protein anabolic effects require sufficient nutritional supply. During fasting and caloric restriction GH predominantly promotes fat metabolism. GH counteracts the effect of insulin in many tissues, of which insulin-stimulated glucose uptake in skeletal muscle has been most ...

Phase N/A

Corticosteroid Rhythms in Hypoparathyroid Patients

Visit 1: Optimizing conventional treatment regarding s-magnesium, s-calcium, s-phosphorous and 25-hydroxyvitamin D (25(OH)D)-levels. Visit 2 (In-hospital 4-7 days): Day one: 24h microdialysis sampling, venous blood sampling and 24h urine will be collected. Day 2: Start of PTH pump-treatment. Day 3-x: dose adjustment of PTH pump therapy according to Calcium Levels, ...

Phase N/A